CRISPR decodes the RNA regulatory network in prostate cancer: A review from mechanisms to precision therapeutics

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Prostate cancer (PCa) is a leading cause of cancer-related deaths in men globally.
• PCa's heterogeneity and resistance to therapy necessitate deeper understanding of its RNA regulation for precision medicine.
• Current knowledge of PCa's RNA regulatory network is insufficient for effective therapeutic development.

Purpose of the Study:

• To systematically review the applications of CRISPR technology in studying PCa's RNA regulatory network.
• To highlight CRISPR's role in functional decoding, target screening, diagnostics, and intervention for PCa.
• To synthesize how RNA insights advance novel therapeutic strategies and precision medicine in PCa.

Main Methods:

• Systematic literature review of CRISPR applications in PCa RNA research.
• Analysis of CRISPR's utility in studying various RNA types (mRNA, miRNA, circRNA, lncRNA, eRNA, m 6 Aa).
• Synthesis of findings linking RNA mechanisms to PCa progression and therapeutic resistance.

Main Results:

• CRISPR systems are powerful tools for functional RNA analysis and target identification in PCa.
• CRISPR aids in understanding RNA roles in PCa initiation, progression, drug resistance, and metastasis.
• Insights from CRISPR-based RNA studies drive innovation in PCa therapeutics like mRNA vaccines and RNA editing.

Conclusions:

• CRISPR technology is pivotal for dissecting PCa's RNA regulatory network, advancing precision medicine.
• Understanding RNA functions through CRISPR facilitates the development of novel diagnostic and therapeutic strategies for PCa.
• Future integration of CRISPR-RNA therapeutics with multi-omics holds promise for personalized PCa treatment.